ID   ARC_RAT                 Reviewed;         396 AA.
AC   Q63053; Q62743;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 132.
DE   RecName: Full=Activity-regulated cytoskeleton-associated protein {ECO:0000303|PubMed:7857651};
DE   AltName: Full=Activity-regulated gene 3.1 protein {ECO:0000250|UniProtKB:Q9WV31};
DE            Short=ARC/ARG3.1 {ECO:0000250|UniProtKB:Q9WV31};
DE            Short=Arg3.1 {ECO:0000250|UniProtKB:Q9WV31};
GN   Name=Arc {ECO:0000303|PubMed:7857651, ECO:0000312|RGD:62037};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   DEVELOPMENTAL STAGE, AND INDUCTION.
RC   TISSUE=Hippocampus;
RX   PubMed=7857651; DOI=10.1016/0896-6273(95)90299-6;
RA   Lyford G.L., Yamagata K., Kaufmann W.E., Barnes C.A., Sanders L.K.,
RA   Copeland N.G., Gilbert D.J., Jenkins N.A., Lanahan A.A., Worley P.F.;
RT   "Arc, a growth factor and activity-regulated gene, encodes a novel
RT   cytoskeleton-associated protein that is enriched in neuronal dendrites.";
RL   Neuron 14:433-445(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RX   PubMed=7777577; DOI=10.1073/pnas.92.12.5734;
RA   Link W., Konietzko U., Kauselmann G., Krug M., Schwanke B., Frey U.,
RA   Kuhl D.;
RT   "Somatodendritic expression of an immediate early gene is regulated by
RT   synaptic activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:5734-5738(1995).
RN   [3]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=9808461; DOI=10.1016/s0896-6273(00)80591-7;
RA   Steward O., Wallace C.S., Lyford G.L., Worley P.F.;
RT   "Synaptic activation causes the mRNA for the IEG Arc to localize
RT   selectively near activated postsynaptic sites on dendrites.";
RL   Neuron 21:741-751(1998).
RN   [4]
RP   INDUCTION.
RX   PubMed=10570490; DOI=10.1038/16046;
RA   Guzowski J.F., McNaughton B.L., Barnes C.A., Worley P.F.;
RT   "Environment-specific expression of the immediate-early gene Arc in
RT   hippocampal neuronal ensembles.";
RL   Nat. Neurosci. 2:1120-1124(1999).
RN   [5]
RP   FUNCTION.
RX   PubMed=10818134; DOI=10.1523/jneurosci.20-11-03993.2000;
RA   Guzowski J.F., Lyford G.L., Stevenson G.D., Houston F.P., McGaugh J.L.,
RA   Worley P.F., Barnes C.A.;
RT   "Inhibition of activity-dependent arc protein expression in the rat
RT   hippocampus impairs the maintenance of long-term potentiation and the
RT   consolidation of long-term memory.";
RL   J. Neurosci. 20:3993-4001(2000).
RN   [6]
RP   INDUCTION.
RX   PubMed=11226315; DOI=10.1073/pnas.051623398;
RA   Pinkstaff J.K., Chappell S.A., Mauro V.P., Edelman G.M., Krushel L.A.;
RT   "Internal initiation of translation of five dendritically localized
RT   neuronal mRNAs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:2770-2775(2001).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH DNM2; SH3GL1 AND
RP   SH3GL3.
RX   PubMed=17088211; DOI=10.1016/j.neuron.2006.08.033;
RA   Chowdhury S., Shepherd J.D., Okuno H., Lyford G., Petralia R.S., Plath N.,
RA   Kuhl D., Huganir R.L., Worley P.F.;
RT   "Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA
RT   receptor trafficking.";
RL   Neuron 52:445-459(2006).
RN   [8]
RP   FUNCTION.
RX   PubMed=17088212; DOI=10.1016/j.neuron.2006.09.031;
RA   Rial Verde E.M., Lee-Osbourne J., Worley P.F., Malinow R., Cline H.T.;
RT   "Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA
RT   receptor-mediated synaptic transmission.";
RL   Neuron 52:461-474(2006).
RN   [9]
RP   FUNCTION.
RX   PubMed=17088213; DOI=10.1016/j.neuron.2006.08.034;
RA   Shepherd J.D., Rumbaugh G., Wu J., Chowdhury S., Plath N., Kuhl D.,
RA   Huganir R.L., Worley P.F.;
RT   "Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA Receptors.";
RL   Neuron 52:475-484(2006).
RN   [10]
RP   INDUCTION.
RX   PubMed=18614031; DOI=10.1016/j.neuron.2008.05.014;
RA   Waung M.W., Pfeiffer B.E., Nosyreva E.D., Ronesi J.A., Huber K.M.;
RT   "Rapid translation of Arc/Arg3.1 selectively mediates mGluR-dependent LTD
RT   through persistent increases in AMPAR endocytosis rate.";
RL   Neuron 59:84-97(2008).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CAMK2B.
RX   PubMed=22579289; DOI=10.1016/j.cell.2012.02.062;
RA   Okuno H., Akashi K., Ishii Y., Yagishita-Kyo N., Suzuki K., Nonaka M.,
RA   Kawashima T., Fujii H., Takemoto-Kimura S., Abe M., Natsume R.,
RA   Chowdhury S., Sakimura K., Worley P.F., Bito H.;
RT   "Inverse synaptic tagging of inactive synapses via dynamic interaction of
RT   Arc/Arg3.1 with CaMKIIbeta.";
RL   Cell 149:886-898(2012).
RN   [12]
RP   FUNCTION.
RX   PubMed=23791196; DOI=10.1016/j.neuron.2013.04.036;
RA   Mikuni T., Uesaka N., Okuno H., Hirai H., Deisseroth K., Bito H., Kano M.;
RT   "Arc/Arg3.1 is a postsynaptic mediator of activity-dependent synapse
RT   elimination in the developing cerebellum.";
RL   Neuron 78:1024-1035(2013).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND RNA-BINDING.
RX   PubMed=29328916; DOI=10.1016/j.cell.2017.12.024;
RA   Pastuzyn E.D., Day C.E., Kearns R.B., Kyrke-Smith M., Taibi A.V.,
RA   McCormick J., Yoder N., Belnap D.M., Erlendsson S., Morado D.R.,
RA   Briggs J.A.G., Feschotte C., Shepherd J.D.;
RT   "The neuronal gene Arc encodes a repurposed retrotransposon Gag protein
RT   that mediates intercellular RNA transfer.";
RL   Cell 172:275-288(2018).
RN   [14]
RP   SUBUNIT.
RX   PubMed=30028513; DOI=10.1111/jnc.14556;
RA   Hallin E.I., Eriksen M.S., Baryshnikov S., Nikolaienko O., Groedem S.,
RA   Hosokawa T., Hayashi Y., Bramham C.R., Kursula P.;
RT   "Structure of monomeric full-length ARC sheds light on molecular
RT   flexibility, protein interactions, and functional modalities.";
RL   J. Neurochem. 147:323-343(2018).
RN   [15] {ECO:0007744|PDB:4X3H, ECO:0007744|PDB:4X3I, ECO:0007744|PDB:4X3X}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 207-277, AND DOMAIN.
RX   PubMed=25864631; DOI=10.1016/j.neuron.2015.03.030;
RA   Zhang W., Wu J., Ward M.D., Yang S., Chuang Y.A., Xiao M., Li R.,
RA   Leahy D.J., Worley P.F.;
RT   "Structural basis of arc binding to synaptic proteins: implications for
RT   cognitive disease.";
RL   Neuron 86:490-500(2015).
RN   [16]
RP   STRUCTURE BY NMR OF 206-364, SUBUNIT, AND INTERACTION WITH GRIN2A AND
RP   GRIN2B.
RX   PubMed=31080121; DOI=10.1016/j.str.2019.04.001;
RA   Nielsen L.D., Pedersen C.P., Erlendsson S., Teilum K.;
RT   "The capsid domain of Arc changes its oligomerization propensity through
RT   direct interaction with the NMDA receptor.";
RL   Structure 0:0-0(2019).
CC   -!- FUNCTION: Master regulator of synaptic plasticity that self-assembles
CC       into virion-like capsids that encapsulate RNAs and mediate
CC       intercellular RNA transfer in the nervous system (PubMed:29328916). ARC
CC       protein is released from neurons in extracellular vesicles that mediate
CC       the transfer of ARC mRNA into new target cells, where ARC mRNA can
CC       undergo activity-dependent translation (PubMed:29328916). ARC capsids
CC       are endocytosed and are able to transfer ARC mRNA into the cytoplasm of
CC       neurons (PubMed:29328916). Acts as a key regulator of synaptic
CC       plasticity: required for protein synthesis-dependent forms of long-term
CC       potentiation (LTP) and depression (LTD) and for the formation of long-
CC       term memory (PubMed:10818134, PubMed:17088211, PubMed:17088212,
CC       PubMed:17088213). Regulates synaptic plasticity by promoting
CC       endocytosis of AMPA receptors (AMPARs) in response to synaptic
CC       activity: this endocytic pathway maintains levels of surface AMPARs in
CC       response to chronic changes in neuronal activity through synaptic
CC       scaling, thereby contributing to neuronal homeostasis (PubMed:17088211,
CC       PubMed:17088212). Acts as a postsynaptic mediator of activity-dependent
CC       synapse elimination in the developing cerebellum by mediating
CC       elimination of surplus climbing fiber synapses (PubMed:23791196).
CC       Accumulates at weaker synapses, probably to prevent their undesired
CC       enhancement (PubMed:22579289). This suggests that ARC-containing
CC       virion-like capsids may be required to eliminate synaptic material
CC       (PubMed:29328916). Required to transduce experience into long-lasting
CC       changes in visual cortex plasticity and for long-term memory
CC       (PubMed:10818134). Involved in postsynaptic trafficking and processing
CC       of amyloid-beta A4 (APP) via interaction with PSEN1 (By similarity). In
CC       addition to its role in synapses, also involved in the regulation of
CC       the immune system: specifically expressed in skin-migratory dendritic
CC       cells and regulates fast dendritic cell migration, thereby regulating
CC       T-cell activation (By similarity). {ECO:0000250|UniProtKB:Q9WV31,
CC       ECO:0000269|PubMed:10818134, ECO:0000269|PubMed:17088211,
CC       ECO:0000269|PubMed:17088212, ECO:0000269|PubMed:17088213,
CC       ECO:0000269|PubMed:22579289, ECO:0000269|PubMed:23791196,
CC       ECO:0000269|PubMed:29328916}.
CC   -!- SUBUNIT: Homooligomer; homooligomerizes into virion-like capsids
CC       (PubMed:29328916, PubMed:30028513, PubMed:31080121). Interacts with
CC       SH3GL1/endophilin-2, SH3GL3/endophilin-3 and DNM2/DYN2
CC       (PubMed:17088211). Interacts with CAMK2B (in the kinase inactive
CC       state); leading to target ARC to inactive synapses (PubMed:22579289).
CC       Interacts with PSEN1 (By similarity). Interacts with GRIN2A and GRIN2B;
CC       inhibiting homooligomerization (PubMed:31080121).
CC       {ECO:0000250|UniProtKB:Q9WV31, ECO:0000269|PubMed:17088211,
CC       ECO:0000269|PubMed:22579289, ECO:0000269|PubMed:29328916,
CC       ECO:0000269|PubMed:30028513, ECO:0000269|PubMed:31080121}.
CC   -!- INTERACTION:
CC       Q63053; P08413: Camk2b; NbExp=6; IntAct=EBI-5275794, EBI-916155;
CC       Q63053; PRO_0000025591 [P49768]: PSEN1; Xeno; NbExp=3; IntAct=EBI-5275794, EBI-2606326;
CC   -!- SUBCELLULAR LOCATION: Extracellular vesicle membrane
CC       {ECO:0000269|PubMed:29328916}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:Q9WV31}. Postsynaptic cell membrane
CC       {ECO:0000250|UniProtKB:Q9WV31}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:Q9WV31}. Synapse {ECO:0000269|PubMed:17088211,
CC       ECO:0000269|PubMed:22579289}. Postsynaptic density
CC       {ECO:0000269|PubMed:17088211}. Early endosome membrane
CC       {ECO:0000269|PubMed:17088211}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:7857651, ECO:0000269|PubMed:9808461}. Cytoplasm,
CC       cytoskeleton {ECO:0000269|PubMed:7857651}. Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:7857651}. Cell projection, dendritic spine
CC       {ECO:0000269|PubMed:17088211}. Cytoplasmic vesicle, secretory vesicle,
CC       acrosome {ECO:0000250|UniProtKB:Q9WV31}. Cytoplasmic vesicle, clathrin-
CC       coated vesicle membrane {ECO:0000250|UniProtKB:Q7LC44}. Note=Forms
CC       virion-like extracellular vesicles that are released from neurons
CC       (PubMed:29328916). Enriched in postsynaptic density of dendritic spines
CC       (PubMed:17088211). Targeted to inactive synapses following interaction
CC       with CAMK2B in the kinase inactive state (PubMed:22579289).
CC       Accumulation at weaker synapses may be required to prevent their
CC       undesired enhancement (PubMed:22579289). Associated with the cell
CC       cortex of neuronal soma and dendrites (PubMed:7857651). Associated with
CC       the sperm tail (By similarity). {ECO:0000250|UniProtKB:Q7LC44,
CC       ECO:0000250|UniProtKB:Q9WV31, ECO:0000269|PubMed:17088211,
CC       ECO:0000269|PubMed:22579289, ECO:0000269|PubMed:29328916,
CC       ECO:0000269|PubMed:7777577, ECO:0000269|PubMed:7857651}.
CC   -!- TISSUE SPECIFICITY: Expressed exclusively in certain parts of the brain
CC       including cortex and molecular layer of the hippocampus. Typically
CC       expressed at high level in a minority of neurons. Basal expression
CC       higher in cortex than in hippocampus, highest in visual cortex.
CC       {ECO:0000269|PubMed:7777577, ECO:0000269|PubMed:7857651}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during postnatal development from day 8
CC       (PubMed:7857651). Highest expression around day 23 with moderate levels
CC       expressed to adulthood (PubMed:7857651). {ECO:0000269|PubMed:7857651}.
CC   -!- INDUCTION: Arc expression is regulated at transcription, post-
CC       transcription and translation levels (PubMed:10570490, PubMed:11226315,
CC       PubMed:18614031, PubMed:9808461). Transcription is tightly coupled to
CC       encoding of information in neuronal circuits (PubMed:10570490).
CC       Expression is induced by neuronal and synaptic activity
CC       (PubMed:10570490, PubMed:7777577, PubMed:7857651). Induced at highest
CC       level in hippocampus within 30 minutes, dropping to basal levels within
CC       24 hours (PubMed:7777577, PubMed:7857651). Arc transcripts are
CC       transported to dendrites and become enriched at sites of local synaptic
CC       activity where they are locally translated into protein
CC       (PubMed:18614031, PubMed:9808461). Arc transcripts resemble some viral
CC       RNAs and contain an internal ribosomal entry site (IRES) that allows
CC       cap-independent translation (PubMed:11226315).
CC       {ECO:0000269|PubMed:10570490, ECO:0000269|PubMed:11226315,
CC       ECO:0000269|PubMed:18614031, ECO:0000269|PubMed:7777577,
CC       ECO:0000269|PubMed:7857651, ECO:0000269|PubMed:9808461}.
CC   -!- DOMAIN: The protein is evolutionarily related to retrotransposon Gag
CC       proteins: it contains large N- and C-terminal domains that form a bi-
CC       lobar architecture similar to the capsid domain of human
CC       immunodeficiency virus (HIV) gag protein (PubMed:25864631,
CC       PubMed:29328916). It contains structural elements found within viral
CC       Gag polyproteins originated from the Ty3/gypsy retrotransposon family
CC       and retains the ability to form virion-like capsid structures that can
CC       mediate mRNA transfer between cells (PubMed:29328916). Tetrapod and fly
CC       Arc protein-coding genes originated independently from distinct
CC       lineages of Ty3/gypsy retrotransposons (PubMed:29328916).
CC       {ECO:0000269|PubMed:25864631, ECO:0000269|PubMed:29328916}.
CC   -!- PTM: Palmitoylation anchors the protein into the membrane by allowing
CC       direct insertion into the hydrophobic core of the lipid bilayer.
CC       {ECO:0000250|UniProtKB:Q9WV31}.
CC   -!- PTM: Ubiquitinated by UBE3A, leading to its degradation by the
CC       proteasome, thereby promoting AMPA receptors (AMPARs) expression at
CC       synapses. Ubiquitinated by RNF216 at Lys-268 and Lys-269 limiting ARC
CC       protein levels induced by synaptic activity and thus regulating ARC-
CC       dependent forms of synaptic plasticity. {ECO:0000250|UniProtKB:Q7LC44,
CC       ECO:0000250|UniProtKB:Q9WV31}.
CC   -!- PTM: Phosphorylation at Ser-260 by CaMK2 prevents homooligomerization
CC       into virion-like capsids by disrupting an interaction surface essential
CC       for high-order oligomerization. Phosphorylation by CaMK2 inhibits
CC       synaptic activity. {ECO:0000250|UniProtKB:Q9WV31}.
CC   -!- MISCELLANEOUS: Transcripts enriched in dendrites may be translated
CC       locally. {ECO:0000269|PubMed:7777577}.
CC   -!- SIMILARITY: Belongs to the ARC/ARG3.1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U19866; AAA68695.1; -; mRNA.
DR   EMBL; Z46925; CAA87033.1; -; mRNA.
DR   PIR; I58168; I58168.
DR   RefSeq; NP_062234.1; NM_019361.1.
DR   RefSeq; XP_017450553.1; XM_017595064.1.
DR   PDB; 4X3H; X-ray; 2.40 A; A=207-277.
DR   PDB; 4X3I; X-ray; 1.80 A; A=207-277.
DR   PDB; 4X3X; X-ray; 2.00 A; A=278-362.
DR   PDB; 6GSE; NMR; -; A=206-364.
DR   PDB; 7R24; X-ray; 2.70 A; A=1-396.
DR   PDBsum; 4X3H; -.
DR   PDBsum; 4X3I; -.
DR   PDBsum; 4X3X; -.
DR   PDBsum; 6GSE; -.
DR   PDBsum; 7R24; -.
DR   AlphaFoldDB; Q63053; -.
DR   SMR; Q63053; -.
DR   BioGRID; 248539; 8.
DR   IntAct; Q63053; 6.
DR   STRING; 10116.ENSRNOP00000063719; -.
DR   iPTMnet; Q63053; -.
DR   PhosphoSitePlus; Q63053; -.
DR   PaxDb; 10116-ENSRNOP00000063719; -.
DR   Ensembl; ENSRNOT00000076998.3; ENSRNOP00000068090.1; ENSRNOG00000043465.4.
DR   Ensembl; ENSRNOT00055043515; ENSRNOP00055035508; ENSRNOG00055025242.
DR   Ensembl; ENSRNOT00060040062; ENSRNOP00060033063; ENSRNOG00060023163.
DR   Ensembl; ENSRNOT00065015439; ENSRNOP00065011615; ENSRNOG00065009634.
DR   GeneID; 54323; -.
DR   KEGG; rno:54323; -.
DR   UCSC; RGD:62037; rat.
DR   AGR; RGD:62037; -.
DR   CTD; 23237; -.
DR   RGD; 62037; Arc.
DR   eggNOG; ENOG502QSPT; Eukaryota.
DR   GeneTree; ENSGT00390000003914; -.
DR   HOGENOM; CLU_782004_0_0_1; -.
DR   InParanoid; Q63053; -.
DR   OMA; WEYKQGS; -.
DR   OrthoDB; 4578527at2759; -.
DR   PhylomeDB; Q63053; -.
DR   TreeFam; TF335604; -.
DR   EvolutionaryTrace; Q63053; -.
DR   PRO; PR:Q63053; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000043465; Expressed in frontal cortex and 16 other cell types or tissues.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:RGD.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0030665; C:clathrin-coated vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0043197; C:dendritic spine; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:1903561; C:extracellular vesicle; IDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0071598; C:neuronal ribonucleoprotein granule; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0098845; C:postsynaptic endosome; IDA:SynGO.
DR   GO; GO:0170047; C:virus-like capsid; ISO:RGD.
DR   GO; GO:0003729; F:mRNA binding; IDA:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; ISO:RGD.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0007010; P:cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0007492; P:endoderm development; ISO:RGD.
DR   GO; GO:0007612; P:learning; IEP:RGD.
DR   GO; GO:0007616; P:long-term memory; IMP:UniProtKB.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0051028; P:mRNA transport; IDA:UniProtKB.
DR   GO; GO:2000969; P:positive regulation of AMPA receptor activity; IMP:CACAO.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0022604; P:regulation of cell morphogenesis; ISS:UniProtKB.
DR   GO; GO:0061001; P:regulation of dendritic spine morphogenesis; IGI:ARUK-UCL.
DR   GO; GO:1900452; P:regulation of long-term synaptic depression; ISS:UniProtKB.
DR   GO; GO:1900271; P:regulation of long-term synaptic potentiation; IMP:UniProtKB.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; IEP:RGD.
DR   GO; GO:0099149; P:regulation of postsynaptic neurotransmitter receptor internalization; ISO:RGD.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0043278; P:response to morphine; IEP:RGD.
DR   GO; GO:0110077; P:vesicle-mediated intercellular transport; IDA:UniProtKB.
DR   InterPro; IPR023263; Arc.
DR   InterPro; IPR040814; Arc_C.
DR   InterPro; IPR048965; Arc_capsid_dom.
DR   InterPro; IPR045557; Arc_N.
DR   PANTHER; PTHR15962; ACTIVITY-REGULATED CYTOSKELETON-ASSOCIATED PROTEIN; 1.
DR   PANTHER; PTHR15962:SF0; ACTIVITY-REGULATED CYTOSKELETON-ASSOCIATED PROTEIN; 1.
DR   Pfam; PF18162; Arc_C; 1.
DR   Pfam; PF21395; Arc_capsid_dom; 1.
DR   Pfam; PF19284; Arc_MA; 1.
DR   PRINTS; PR02027; ARCARG31.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cell projection; Coiled coil; Cytoplasm;
KW   Cytoplasmic vesicle; Cytoskeleton; Developmental protein; Endocytosis;
KW   Endosome; Isopeptide bond; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Postsynaptic cell membrane; Reference proteome;
KW   RNA-binding; Synapse; Transport; Ubl conjugation.
FT   CHAIN           1..396
FT                   /note="Activity-regulated cytoskeleton-associated protein"
FT                   /id="PRO_0000273287"
FT   REGION          89..100
FT                   /note="Interaction with SH3GL1 or SH3GL3"
FT                   /evidence="ECO:0000269|PubMed:17088211"
FT   REGION          195..214
FT                   /note="Interaction with DNM2"
FT                   /evidence="ECO:0000269|PubMed:17088211"
FT   REGION          358..396
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          54..78
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        378..396
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         260
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WV31"
FT   MOD_RES         278
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WV31"
FT   CROSSLNK        268
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q7LC44"
FT   CROSSLNK        269
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q7LC44"
FT   CONFLICT        209
FT                   /note="V -> L (in Ref. 1; AAA68695)"
FT                   /evidence="ECO:0000305"
FT   HELIX           207..210
FT                   /evidence="ECO:0007829|PDB:4X3I"
FT   STRAND          211..216
FT                   /evidence="ECO:0007829|PDB:4X3I"
FT   HELIX           217..231
FT                   /evidence="ECO:0007829|PDB:4X3I"
FT   HELIX           235..239
FT                   /evidence="ECO:0007829|PDB:4X3I"
FT   HELIX           240..245
FT                   /evidence="ECO:0007829|PDB:4X3I"
FT   HELIX           249..257
FT                   /evidence="ECO:0007829|PDB:4X3I"
FT   HELIX           258..260
FT                   /evidence="ECO:0007829|PDB:4X3I"
FT   HELIX           264..276
FT                   /evidence="ECO:0007829|PDB:4X3I"
FT   HELIX           279..288
FT                   /evidence="ECO:0007829|PDB:4X3X"
FT   HELIX           298..312
FT                   /evidence="ECO:0007829|PDB:4X3X"
FT   HELIX           318..327
FT                   /evidence="ECO:0007829|PDB:4X3X"
FT   HELIX           331..337
FT                   /evidence="ECO:0007829|PDB:4X3X"
FT   TURN            338..340
FT                   /evidence="ECO:0007829|PDB:4X3X"
FT   HELIX           345..359
FT                   /evidence="ECO:0007829|PDB:4X3X"
SQ   SEQUENCE   396 AA;  45353 MW;  4E95B46B75853CA5 CRC64;
     MELDHMTTGG LHAYPAPRGG PAAKPNVILQ IGKCRAEMLE HVRRTHRHLL TEVSKQVERE
     LKGLHRSVGK LENNLDGYVP TGDSQRWKKS IKACLCRCQE TIANLERWVK REMHVWREVF
     YRLERWADRL ESMGGKYPVG SEPARHTVSV GVGGPEPYCQ EADGYDYTVS PYAITPPPAA
     GELPEQESVG AQQYQSWVPG EDGQPSPGVD TQIFEDPREF LSHLEEYLRQ VGGSEEYWLS
     QIQNHMNGPA KKWWEFKQGS VKNWVEFKKE FLQYSEGTLS REAIQRELDL PQKQGEPLDQ
     FLWRKRDLYQ TLYVDAEEEE IIQYVVGTLQ PKFKRFLRHP LPKTLEQLIQ RGMEVQDGLE
     QAAEPSVTPL PTEDETEALT PALTSESVAS DRTQPE
//
